Noninterventional Study Evaluating Parkinson's Disease Diary Use

NCT05363046 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 194

Last updated 2024-07-31

No results posted yet for this study

Summary

This study aims to evaluate the impact of the frequency of assessments on the variability over time, reliability, and compliance for the Parkinson's disease (PD) diary in patients with PD in whom medications do not provide adequate control of symptoms.

Conditions

Sponsors & Collaborators

  • BlueRock Therapeutics

    lead INDUSTRY

Eligibility

Min Age
39 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-29
Primary Completion
2025-10-31
Completion
2026-10-31

Countries

  • United States
  • Canada
  • Germany
  • Italy
  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05363046 on ClinicalTrials.gov